CTOs on the Move


 
Founded in 1998, Novation is the leading health care supply chain expertise, analytics and contracting company for the more than 100,000 members of VHA Inc. and UHC, two national health care alliances, Children's Hospital Association, an alliance of the nation's leading pediatric facilities, and Provista, LLC. Novation provides alliance members with sourcing services, as well as information and data services. Based in Irving, Texas, Novation develops and manages competitive contracts with more than 600 suppliers. VHA, UHC, Children’s Hospital Association, and Provista members used Novation contracts to purchase more than $43 billion in 2012.
  • Number of Employees: 100-250
  • Annual Revenue: $50-100 Million

Executives

Name Title Contact Details

Similar Companies

Trenton Orthopaedic Group, PA

Trenton Orthopaedic Group, PA is a Trenton, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

MicroAire Surgical Instruments

MicroAire Surgical Instruments is a Charlottesville, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Nuehealth

NueHealth is building a nationwide system of clinically integrated provider networks that puts healthcare into the hands of consumers. With a vast network of purpose-driven surgical centers and hospitals, NueHealth connects providers directly to consumers and aids them in delivering value-based payment options and improved outcomes. To deliver this improved value, NueHealth leverages proprietary technologies, online platforms, bundled payments and targeted programs and services. NueHealth gives providers and payors the tools and resources to stay ahead of healthcare’s continued evolution, while giving employers, insurance companies and patients access to a simplified model and affordable, high-quality, streamlined care.

Vertebral Technologies

Vertebral Technologies, Inc. is a Minnetonka, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Maverick Therapeutics

Maverick Therapeutics is pioneering the next generation of redirected T-cell targeted immunotherapies. Mavericks highly innovative platform, COBRA™, is the most advanced bispecific T-cell engaging platform in its class, designed to safely target solid tumors with highly specific and potent activity.